These patients may represent the first individuals with DECR1 deficiency, then defining within MASLD an autosomal-recessive entity, well corresponding to the reported steatotic liver disease in Decr1 knockout mice. Here, DECR1 is linked to metabolic dysfunction-associated steatotic liver disease.